Sudocrem boss: new skin drug will net €1.5bn

Drug will be used to treat epidermolysis bullosa

Iconic brand, Sudocrem Pic: Getty
Rory Nealon will take the reins of Amryt while also serving as chief operating officer

A new publicly quoted pharmaceutical company backed by Sudocrem founder Dr Ray Stafford is predicting revenues of up to $1.5 billion from one of its drugs, which is used to treat rare genetic skin disorders.

The drug, which is currently going through ...